| Literature DB >> 34901384 |
Michael Taeyoung Hwang1, Insu Park2, Mohammad Heiranian3, Amir Taqieddin3, Seungyong You2, Vahid Faramarzi4, Angela A Pak5, Arend M van der Zande3,5, Narayana R Aluru5,6, Rashid Bashir2,3,4,5.
Abstract
Universal platforms for biomolecular analysis using label-free sensing modalities can address important diagnostic challenges. Electrical field effect-sensors are an important class of devices that can enable point-of-care sensing by probing the charge in the biological entities. Use of crumpled graphene for this application is especially promising. It is previously reported that the limit of detection (LoD) on electrical field effect-based sensors using DNA molecules on the crumpled graphene FET (field-effect transistor) platform. Here, the crumpled graphene FET-based biosensing of important biomarkers including small molecules and proteins is reported. The performance of devices is systematically evaluated and optimized by studying the effect of the crumpling ratio on electrical double layer (EDL) formation and bandgap opening on the graphene. It is also shown that a small and electroneutral molecule dopamine can be captured by an aptamer and its conformation change induced electrical signal changes. Three kinds of proteins were captured with specific antibodies including interleukin-6 (IL-6) and two viral proteins. All tested biomarkers are detectable with the highest sensitivity reported on the electrical platform. Significantly, two COVID-19 related proteins, nucleocapsid (N-) and spike (S-) proteins antigens are successfully detected with extremely low LoDs. This electrical antigen tests can contribute to the challenge of rapid, point-of-care diagnostics.Entities:
Keywords: COVID‐19 antigen test; COVID‐19 proteins detection; S‐ and N‐protein; crumpled graphene FET biosensor; dopamine detection
Year: 2021 PMID: 34901384 PMCID: PMC8646936 DOI: 10.1002/admt.202100712
Source DB: PubMed Journal: Adv Mater Technol
Figure 1Schematics and characterization of crumpled graphene FET biosensor. a): i) Scheme of crumpled graphene FET biosensor; “S” is source, “G” is liquid gate, and “D” is drain electrodes. ii) Dopamine detection with aptamer probe and iii) various proteins detection with specific antibodies on the crumpled graphene channels. iv) Scheme and the lateral section of COVID‐19 virus which show targeted viral proteins for the proposed antigen test with crumpled graphene FET. b) SEM images of flat and different crumpling ratios of graphene. SEM images of i) flat graphene and ii–iv) with 10–60% of crumpling ratios. v–viii) SEM images of same samples of i–iv) with a larger scale. Scale bars and crumpling ratios are indicated on images.
Figure 2The molar concentration of ions (sodium and chloride) and the backbone of COVID‐19 RNA strand segment along with the screening factor of ions are plotted as a function of the distance from the graphene surface for a) flat, b) 10%, c) 30%, d) 50%, and e) 70% crumpled graphene. The configurations of different graphene (in cyan) are illustrated. In concave regions of crumpled graphene, ions are excluded due to its confinement and most of the adsorbed COVID‐19 RNA molecule remains unscreened electrostatically. As the degree of crumpling increases, more of the RNA molecules are exposed to the graphene surface without being electrostatically screened by ions resulting in enhanced RNA detection. f) Summary table of the simulations.
Figure 3Characterization of crumpling ratio effects. a) EDL capacitance of the graphene samples with crumpling ratio of i) 10%, ii) 30%, iii) 40%, and iv) 60%. b) Strain analysis via confocal Raman spectroscopy. i) Raw Raman spectrum of graphene with various crumpling ratios. ii) 2D peak position map of graphene with various crumpling ratios. Scale bars: 1 µm. iii) 2D Raw Raman spectrum of (ii) (iv) 2D peak position graph of (iii). c) AFM image of (i) 40% and (ii) 60% crumpled graphene. 3D AFM image of (iii) 40% and (iv) 60% crumpled graphene. d) Dirac point shift by ssDNA absorption on graphene FET sensors with various crumpling ratios.
Figure 4Dopamine detections on graphene FET biosensors. a) Schematic of dopamine capturing with aptamer on the crumpled graphene channel. b) I–V relationship of the crumpled and c) flat graphene FET sensors for the dopamine detection using aptamer probe. d) Dirac voltage shift of the FET sensor with the detection of dopamine in PBS, NC is negative control with no aptamer attached or with serotonin, and e) In aCSF (Artificial cerebrospinal fluid). Sample without aptamer is the negative control sample is aCSF only which has only chemicals typically present, and sample with Dopamine is aCSF spiked with Dopamine.
Figure 5Various protein detections on graphene FET biosensors. a) Schematic of proteins capturing with specific antibodies on the crumpled graphene channel. b) Dirac voltage shift of the FET sensor with detection of IL‐6 protein, c) COVID‐19 N‐protein, and d) S‐protein.